Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Board memberships
- Royalty Pharma plc
Updated Jul 16, 2026
Norden Gregory has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.38M.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | PRAX | Praxis Precision Medicines, Inc. | A — Grant or award | 1.4K | $0.00 | |
| 2026-06-08 | RPRX | Royalty Pharma plc | A — Grant or award | 4.5K | $0.00 | |
| 2026-05-15 | RPRX | Royalty Pharma plc | S — Open-market sale | 3.0K | $53.00 | $161K |
| 2026-03-10 | ZTS | Zoetis Inc. | G — Bona-fide gift | 1.2K | $0.00 | |
| 2026-02-23 | ZTS | Zoetis Inc. | J — Other acquisition / disposition | 406 | $127.28 | $52K |
| 2026-02-23 | ZTS | Zoetis Inc. | M — Option exercise | 1.6K | — | |
| 2025-08-08 | RPRX | Royalty Pharma plc | S — Open-market sale | 33.5K | $36.23 | $1.21M |
| 2025-08-08 | RPRX | Royalty Pharma plc | J — Other acquisition / disposition | 144.7K | $0.00 |
Norden Gregory is a corporate insider — currently tracked as Director of Praxis Precision Medicines, Inc. (PRAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.38M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Norden Gregory profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.